{"title":"对癌症和传染病治疗策略的启示","authors":"Elena Locci, Silvia Raymond","doi":"10.36811/jca.2021.110012","DOIUrl":null,"url":null,"abstract":"It is widely known that severe viral infections and cancer disrupt the immune system, including T cells, a process called \"immune fatigue.\" Overcoming immune depletion is the main goal of developing new therapies for cancer or severe viral infections. Called Tpex cells, they can maintain their function for a long time.\n\nKeywords: Cancer; Cells; Tissues, Tumors; Prevention, Prognosis; Diagnosis; Imaging; Screening; Treatment; Management","PeriodicalId":15265,"journal":{"name":"Journal of Chemistry and Applications","volume":"49 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Implications for Treatment Strategies in Cancer and Infectious Diseases\",\"authors\":\"Elena Locci, Silvia Raymond\",\"doi\":\"10.36811/jca.2021.110012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It is widely known that severe viral infections and cancer disrupt the immune system, including T cells, a process called \\\"immune fatigue.\\\" Overcoming immune depletion is the main goal of developing new therapies for cancer or severe viral infections. Called Tpex cells, they can maintain their function for a long time.\\n\\nKeywords: Cancer; Cells; Tissues, Tumors; Prevention, Prognosis; Diagnosis; Imaging; Screening; Treatment; Management\",\"PeriodicalId\":15265,\"journal\":{\"name\":\"Journal of Chemistry and Applications\",\"volume\":\"49 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Chemistry and Applications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36811/jca.2021.110012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Chemistry and Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36811/jca.2021.110012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Implications for Treatment Strategies in Cancer and Infectious Diseases
It is widely known that severe viral infections and cancer disrupt the immune system, including T cells, a process called "immune fatigue." Overcoming immune depletion is the main goal of developing new therapies for cancer or severe viral infections. Called Tpex cells, they can maintain their function for a long time.
Keywords: Cancer; Cells; Tissues, Tumors; Prevention, Prognosis; Diagnosis; Imaging; Screening; Treatment; Management